Clinical Trial Update: Evaluation of Safety and Efficacy of Two Ticagrelor-based De-escalation Antiplatelet Strategies in Acute Coronary Syndrome [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating safety and efficacy of two ticagrelor-based de-escalation antiplatelet strategies in acute coronary syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome
• Non-st-segment Elevation Myocardial Infarction
• St-segment Elevation Myocardial Infarction
• Unstable Angina

Drugs mentioned

• TICAGRELOR (ticagrelor)

Snippet

Sponsor: Collegium Medicum w Bydgoszczy | Conditions: STEMI, NSTEMI | Phase 3 | Status: UNKNOWN